C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/5517 (2006.01) A61P 25/00 (2006.01) C07D 495/14 (2006.01)
Patent
CA 2626180
Methods for treating and preventing anxiety, anxiety-related disorders, schizophrenia and schizophrenia-related disorders are described herein wherein said methods comprise the administration of oxytocin receptor agonists. of formula 1 , or a pharmaceutically acceptable salt thereof: 1 wherein: G1 is (I) of formula 1 , or a pharmaceutically acceptable salt thereof: 2 wherein: G2 is (II)
Méthodes servant à traiter et à prévenir l'anxiété, des troubles associés à l'anxiété, la schizophrénie et des troubles associés à la schizophrénie, ce qui consiste à administrer des agonistes du récepteur d'oxytocine.
Rahman Zia
Resnick Lynn
Ring Robert H.
Rosenzweig-Lipson Sharon Joy
Smart & Biggar
Wyeth
LandOfFree
Tricyclic compounds useful as oxytocin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds useful as oxytocin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds useful as oxytocin receptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1384468